Skip to the page

Data / Form D filings / Enumera Molecular, Inc.

Enumera Molecular, Inc.: Form D filings

Enumera Molecular, Inc., a health care company in Ann Arbor, MI, filed 3 Form D notices with the SEC between 2022 and 2026. The latest, on July 31, 2026, reports $12.3 million sold of a $17.4 million offering to 12 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
600 S. WAGNER RD. BLDG. 1, Ann Arbor, MI, 48103
Phone
(650) 308-8544
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2022
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1929085

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 31, 2026New notice$17,375,672$12,325,344$5,050,32812Jul 16, 2026sec.gov
Aug 22, 2022Amendment$18,970,000$18,720,000$250,0005May 4, 2022sec.gov
May 17, 2022New notice$18,500,000$16,000,000$2,500,0002May 4, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Matthew CooperExecutive Officer, Director
Dan KidleDirector
Elaine HeronDirector
Sundaresh BrahmasandraDirector

Other health care companies in Michigan that filed recently

Every Form D from the week of Jul 27, 2026 · All recent filings in Michigan · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what Enumera Molecular, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.